Sign In
Buy IPSC
$2.07
-0.100 (-4.61%)
At Close: Jun 03, 2026
PHILADELPHIA and MADISON, Wis., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (NASDAQ: IPSC), an innovative clinical-stage biotechnology company developing induced pluripotent stem cell
Century Therapeutics to Present at the Chardan 7th Annual Genetic Medicines Conference
07:00am, Tuesday, 26'th Sep 2023
PHILADELPHIA, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative clinical-stage biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell th
Century Therapeutics, Inc. (IPSC) Reports Q1 Loss, Lags Revenue Estimates
10:40am, Thursday, 11'th May 2023
Century Therapeutics, Inc. (IPSC) came out with a quarterly loss of $0.53 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.66 per share a year ago.
Century Therapeutics to Present at Chardan's 7th Annual Genetic Medicines & Cell Therapy Manufacturing Virtual Summit
07:00am, Monday, 17'th Apr 2023
PHILADELPHIA, April 17, 2023 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative clinical-stage biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell th
Century Therapeutics to Present at Upcoming Investor Conferences
07:00am, Tuesday, 21'st Feb 2023
PHILADELPHIA, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative clinical-stage biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell the
Century Therapeutics to Present at Upcoming Investor Conferences
07:00am, Wednesday, 01'st Feb 2023
PHILADELPHIA, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immun
How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
04:03am, Thursday, 26'th Jan 2023
The 2023 calendar year has already been rocky for many biotech companies. Just three weeks into the new year, layoffs are already plaguing the industry.
5 Best and Worst Performing Small-Cap Stocks in Dec 2022
10:59pm, Tuesday, 17'th Jan 2023
Small-cap stocks usually suffer more than mid- and large-cap stocks when the market as a whole is struggling, and when the market is rallying, they could offer higher returns as well.
After Plunging -29.84% in 4 Weeks, Here's Why the Trend Might Reverse for Century Therapeutics, Inc. (IPSC)
11:18am, Tuesday, 17'th Jan 2023
Century Therapeutics, Inc. (IPSC) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street ana
Top 5 Health Care Stocks That May Surge - Graphite Bio (NASDAQ:GRPH), Fate Therapeutics (NASDAQ:FATE)
07:33am, Tuesday, 10'th Jan 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Century Therapeutics closes its Seattle hub amid wider cuts, departure of R&D head
09:06pm, Monday, 09'th Jan 2023
Century Therapeutics is closing its Seattle operations as part of a 25% reduction in headcount and a shift in its priorities.
Century Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
07:00am, Wednesday, 04'th Jan 2023
PHILADELPHIA, Jan. 04, 2023 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immun
Century Therapeutics to Present at the Piper Sandler 34th Annual Healthcare Conference
07:00am, Tuesday, 22'nd Nov 2022
PHILADELPHIA, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immun
Century Therapeutics to Present at the SITC 37th Annual Meeting
04:05pm, Wednesday, 05'th Oct 2022
PHILADELPHIA, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in imm
Century Therapeutics to Present at Chardan's 6th Annual Genetic Medicines Conference
07:00am, Monday, 26'th Sep 2022
PHILADELPHIA, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immu
